Patents by Inventor Kent Bodensgaard

Kent Bodensgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-21 variant nucleic acids
    Patent number: 8383367
    Abstract: IL-21 variants nucleic acid sequences are provided that encode a peptide having deletions and zero to ten conservative amino acid substitutions in the region of amino acid residues 65-96 of SEQ ID. NO:2.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: February 26, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Siv Annegrethe Hjorth, Kent Bodensgaard, Dennis Madsen
  • IL-21 VARIANTS
    Publication number: 20100143292
    Abstract: IL-21 variants are provided wherein amino acids have been deleted in the region consisting of amino acid residues no. 65 to 98.
    Type: Application
    Filed: October 26, 2007
    Publication date: June 10, 2010
    Inventors: Siv Annegrethe Hjorth, Kent Bodensgaard, Dennis Madsen
  • IL-21 Variants
    Publication number: 20090035254
    Abstract: IL-21 variant are provided wherein amino acids have been deleted and/or substituted in the region consisting of amino acid No. 65-96.
    Type: Application
    Filed: April 18, 2006
    Publication date: February 5, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Siv Annegrethe Hjorth, Kent Bodensgaard, Dennis Madsen